Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Open-Label Study of 18F-mFBG for Imaging Neuroblastoma [Phase 3]
Open-label Phase 3 trial evaluating 18F-mFBG for imaging neuroblastoma is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update evaluates natural killer (NK) cell therapy in combination with interleukin for children and young adults with adva…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma [Phase 1]
Phase 1 study of LY3295668 Erbumine in participants with relapsed/refractory neuroblastoma; the trial is currently active but not recruiting…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) [Phase 2]
Phase 2 update from the Pediatric MATCH trial describes targeted therapies matched to tumor genetics in pediatric patients with relapsed or …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma [Phase 1]
A Phase 1 study evaluating the combination of irinotecan and vincristine with 131I-MIBG radiotherapy for resistant/relapsed high-risk neurob…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of a three-drug combination (irinotecan, temozolomide, and cefixime) in young patient…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma [Phase 1]
A Phase 1 clinical trial evaluating intravenous fenretinide in young patients with recurrent or resistant neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation [Phase 1]
This phase 1 trial evaluates a double infusion of Iodine-131 Metaiodobenzylguanidine (I-131 MIBG) followed by autologous stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma [Phase 1]
Phase 1 trial of Fenretinide LXS in patients with recurrent, refractory, or persistent neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) [Phase 1, Phase 2]
Substudy 01A of MK-9999-01A (LIGHTBEAM-U01) evaluates Zilovertamab Vedotin in pediatric and young adult participants with hematologic malign…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma [Phase 1]
Phase I clinical trial update for ThINKK Adoptive Immunotherapy after allogeneic hematopoietic stem cell transplantation in children with ac…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN [Phase 1]
Phase 1 clinical trial evaluating a third-generation GD-2 CAR-T cell therapy with an iCaspase suicide safety switch for neuroblastoma; curre…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma [Phase 1, Phase 2]
This clinical trial update indicates a Phase 1/2 study of dual-target GD2/B7-H3 CAR-NK cells for pediatric relapsed or refractory neuroblast…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
Phase 2 pediatric MATCH trial evaluating IDH1-mutant tumors for response to ivosidenib; results for recurrent and refractory solid tumors, l…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Next Generation Personalized Neuroblastoma Therapy [Phase 1]
A Phase 1 trial of next-generation personalized neuroblastoma therapy has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: An Intermediate Expanded Use Trial of DFMO
This is an update on an intermediate expanded-use trial of DFMO for neuroblastoma and several embryonal CNS tumors, including medulloblastom…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma [Phase 1]
A Phase 1 trial of CUDC-907 (fimepinostat) in children and young adults with relapsed or refractory solid tumors, CNS tumors, or lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: 18F-DOPA II - PET Imaging Optimization [Phase 3]
Phase 3 trial of the imaging agent 18F-DOPA II for PET imaging optimization is currently recruiting, sponsored by the University of Alberta,…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas [Phase 1]
Phase 1 study evaluating CD45RA+ depleted haploidentical stem cell transplantation in children with relapsed or refractory solid tumors and …
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Rapid Administration Pilot for Infusing Dinutuximab [Phase 1]
This clinical trial update reports a Phase 1 pilot study evaluating rapid administration of dinutuximab for neuroblastoma, currently active …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma [Phase 2]
Phase 2 trial evaluating irinotecan hydrochloride, temozolomide, and dinutuximab with or without eflornithine for relapsed or refractory neu…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma [Phase 1]
Phase 1 trial sponsored by the National Cancer Institute evaluated the combination of magrolimab and dinutuximab in pediatric patients with …
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients [Phase 1]
Phase 1 trial assessing EBV-specific cytotoxic T cells engineered to express a GD-2 chimeric antigen receptor in neuroblastoma patients has …
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: MIBG for Refractory Neuroblastoma and Pheochromocytoma [NA]
The clinical trial evaluating MIBG for relapsed neuroblastoma and metastatic pheochromocytoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma [NA]
Clinical trial update indicates hetrombopag is being studied to promote platelet engraftment after autologous hematopoietic stem cell transp…